文献速递乳腺乳腺X线

数字乳腺断层摄影联合合成二维图像与全视野数字乳腺摄影在人群筛查中的比较:维罗纳筛查项目结果

Digital Breast Tomosynthesis with Synthesized Two-Dimensional Images versus Full-Field Digital Mammography for Population Screening: Outcomes from the Verona Screening Program.
PubMed 文献 · Radiology · 2017-12-13

本前瞻性研究纳入2015年4月至2016年3月维罗纳筛查项目中16666名50-69岁无症状女性,接受数字乳腺断层摄影(DBT)联合合成二维(2D)乳腺摄影筛查,并与上一年度接受全视野数字乳腺摄影(FFDM)筛查的14423名女性比较。结果显示DBT联合合成2D成像的癌症检出率高于FFDM(9.30/1000 vs 5.41/1000,RR=1.72),召回阳性预测值几乎翻倍(23.3% vs 12.9%,RR=1.81),召回率相似(RR=0.95),但每小时判读筛查研究数较低(38.5 vs 60,P<.001)。

要点

  • DBT联合合成2D成像较FFDM提高癌症检出率(9.30/1000 vs 5.41/1000,RR=1.72)。
  • DBT联合合成2D成像的召回阳性预测值为23.3%,FFDM为12.9%(RR=1.81)。
  • DBT联合合成2D成像每小时判读筛查研究数为38.5,低于FFDM的60(P<.001)。

核心结论

  • DBT联合合成2D成像提高了癌症检出率,召回率与FFDM相当;但DBT联合合成2D成像增加了图像判读时间和侵入性评估所需时间。

研究设计与样本

  • 前瞻性研究,纳入16666名50-69岁无症状女性,于2015年4月至2016年3月在维罗纳筛查项目中接受DBT联合合成2D筛查;对比队列为上一年度接受FFDM筛查的14423名女性;通过计算各结局比例比较两组筛查检出指标,并用多变量逻辑回归估计相对率(RR)。

诊断标准与关键数值

  • DBT联合合成2D成像的癌症检出率为9.30/1000次筛查,FFDM为5.41/1000次筛查(RR=1.72,95%CI:1.30,2.29)。
  • 低乳腺密度女性中,DBT联合合成2D成像的癌症检出率显著高于FFDM(RR=1.53,95%CI:1.13,2.10)。
  • 高乳腺密度女性中,DBT联合合成2D成像的癌症检出率显著高于FFDM(RR=2.86,95%CI:1.42,6.25)。
  • DBT联合合成2D成像的召回阳性预测值为23.3%,FFDM为12.9%(RR=1.81,95%CI:1.34,2.47)。
  • 两组召回率相似(RR=0.95,95%CI:0.84,1.06);DBT联合合成2D成像的侵入性评估召回率高于FFDM(RR=1.93,95%CI:1.31,2.03)。

临床应用与阅片要点

  • DBT联合合成2D成像可提高癌症检出率,召回率与FFDM相当。
  • 采用DBT联合合成2D成像时需考虑图像判读时间增加(每小时判读38.5例 vs FFDM 60例,P<.001)及侵入性评估时间增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To examine the outcomes of a breast cancer screening program based on digital breast tomosynthesis (DBT) plus synthesized two-dimensional (2D) mammography compared with those after full-field digital mammography (FFDM). Materials and Methods This prospective study included 16 666 asymptomatic women aged 50-69 years who were recruited in April 2015 through March 2016 for DBT plus synthetic 2D screening in the Verona screening program. A comparison cohort of women screened with FFDM (n = 14 423) in the previous year was included. Screening detection measures for the two groups were compared by calculating the proportions associated with each outcome, and the relative rates (RRs) were estimated with multivariate logistic regression. Results Cancer detection rate (CDR) for DBT plus synthetic 2D imaging was 9.30 per 1000 screening examinations versus 5.41 per 1000 screening examinations with FFDM (RR, 1.72; 95% confidence interval [CI]: 1.30, 2.29). CDR was significantly higher in patients screened with DBT plus synthetic 2D imaging than in those screened with FFDM among women classified as having low breast density (RR, 1.53; 95% CI: 1.13, 2.10) or high breast density (RR, 2.86; 95% CI: 1.42, 6.25). The positive predictive value (PPV) for recall was almost doubled with DBT plus synthetic 2D imaging: 23.3% versus 12.9% of recalled patients who were screened with FFDM (RR, 1.81; 95% CI: 1.34, 2.47). The recall rate was similar between groups (RR, 0.95; 95% CI: 0.84, 1.06), whereas the recall rate with invasive assessment was higher for DBT plus synthetic 2D imaging than for FFDM (RR, 1.93; 95% CI: 1.31, 2.03). The mean number of screening studies interpreted per hour was significantly lower for screening examinations performed with DBT plus synthetic 2D imaging (38.5 screens per hour) than with FFDM (60 screens per hour) (P < .001). Conclusion DBT plus synthetic 2D imaging increases CDRs with recall rates comparable to those of FFDM. DBT plus synthetic 2D imaging increased image reading time and the time needed for invasive assessments. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Caumo F, Zorzi M, Brunelli S, et al. Digital Breast Tomosynthesis with Synthesized Two-Dimensional Images versus Full-Field Digital Mammography for Population Screening: Outcomes from the Verona Screening Program. Radiology. 2017. PMID: 29237146. doi:10.1148/radiol.2017170745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。